サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：在宅化学療法サービスの世界市場 - 産業規模、シェア、動向、機会、予測：製品別、投与経路別、がんタイプ別、企業別、地域別（2017年～2027年）
市場調査レポート
商品コード
1166578

在宅化学療法サービスの世界市場 - 産業規模、シェア、動向、機会、予測：製品別、投与経路別、がんタイプ別、企業別、地域別（2017年～2027年）

Chemotherapy At Home Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Product, By Route of Administration, By Cancer Type, By Company, and By Region
出版日: | 発行: TechSci Research | ページ情報: 英文 112 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

在宅化学療法サービスの世界市場 - 産業規模、シェア、動向、機会、予測：製品別、投与経路別、がんタイプ別、企業別、地域別（2017年～2027年）
出版日: 2022年12月01日
発行: TechSci Research
ページ情報: 英文 112 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の在宅化学療法サービス市場は、2023年から2027年の予測期間中に目覚ましい成長を遂げると予測されています。

主な要因は、さまざまなタイプのがんの発生率の増加、在宅医療への選好の高まりが含まれており、市場の成長を後押ししています。市場の成長を支えるその他の要因としては、入院期間の短縮ニーズの高まり、人口の増加、社会行動の変化、政府投資の増加、高齢者人口の増加、化学療法装置の分野における技術的進歩が挙げられます。また、戦略的パートナーシップやコラボレーションも市場の成長を後押ししています。

当レポートでは、世界の在宅化学療法サービス市場について調査し、セグメント別の分析、市場力学、企業プロファイルなどの情報を提供しています。

目次

第1章 サービス概要

第2章 調査手法

第3章 世界の在宅化学療法サービス市場に対するCOVID-19の影響

第4章 エグゼクティブサマリー

第5章 VOC (顧客の声)

  • がんの有病率：性別
  • がんの有病率：年齢層別
  • がんの有病率：地域別
  • 在宅化学療法への移行要因
  • 在宅化学療法サービス導入に対する障壁

第6章 在宅化学療法サービス市場の見通し

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品別（化学療法薬 v/s 化学療法輸液ポンプ）
    • 投与経路別（経口 v/s 静脈注射）
    • がんタイプ別（乳がん、血液がん、卵巣がん、大腸がん、その他）
    • 企業別（2021年）
    • 地域別
  • 市場マップ

第7章 北米の在宅化学療法サービス市場の見通し

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • 投与経路別
    • がんタイプ別
    • 国別
  • 北米：国別分析
    • 米国
    • メキシコ
    • カナダ

第8章 欧州の在宅化学療法サービス市場の見通し

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • 投与経路別
    • がんタイプ別
    • 国別
  • 欧州：国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第9章 アジア太平洋の在宅化学療法サービス市場の見通し

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • 投与経路別
    • がんタイプ別
    • 国別
  • アジア太平洋：国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第10章 南米の在宅化学療法サービス市場の見通し

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • 投与経路別
    • がんタイプ別
    • 国別
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第11章 中東・アフリカの在宅化学療法サービス市場の見通し

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品別
    • 投与経路別
    • がんタイプ別
    • 国別
  • 中東・アフリカ：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場の動向と発展

第14章 競合情勢

  • Portea Medical Pvt. Ltd.
  • HealthCare atHOME
  • Ubiqare Health Pvt. Ltd.
  • Vitalis Health and Home Care Pty Ltd
  • Medibank Private Limited.
  • Advocate Medical Group
  • View Health Pty Ltd
  • CVS Health Corporation

第15章 戦略的提言

目次
Product Code: 12994

The global chemotherapy at home services market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include growing incidences of different types of cancer, and rising preferences towards at-home medical care, are bolstering the growth of the market. Chemotherapy is a medical practice that is mainly conducted for cancer patients. It uses powerful chemicals to kill fast growing cells in human body. The other factors supporting the market's growth are growing need to reduce the period of inpatient stays, the increasing population, changing societal behavior, increasing government investments, growth in geriatric population, and technological advancements in field of chemotherapy devices. Also, strategic partnerships and collaborations are fueling the growth of the market. For instance, CVS Health and the Cancer Treatments Centers of America (CTCA) worked in partnership to bolster the access to chemotherapy at home for eligible patients.

Increasing Incidence of Cancer and Rise in Geriatric Population

Rise in occurrences of various types of cancer such as lung cancer, cervical cancer, breast cancer, and others, are propelling the growth of the market. Cancer is considered as second largest cause of mortality and disability across the globe. According to National Cancer Institute, roughly 5.5 million people in the United States are affected by cancer. This number is projected to rise to 20.3 million by 2026. Owing to the rapid increase in number of patients suffering from cancer, the surge in demand for chemotherapy rises, which augments the growth of chemotherapy at home services market, globally. Furthermore, rising geriatric population is also a key factor contributing the growth of the market. For instance, according to the U.S. Census Bureau, approximately 77.0 million people will be aged 65 & above by 2034, and this number is anticipated to reach 94.7 million by 2060.

Increasing Preference for At-Home Medical Care and Various Technological Advancements

Rising consumer inclination toward at-home medical care is bolstering the market growth, globally. The limited movement capabilities by elderly population are fueling the growth of the market. Rising incidences of hospital infections, and cost effectiveness of these devices are curbing the market growth. For instance, in 2021, as per the study, titled 'Predicting Patients at Risk for Prolonged Hospital Stays', only 1.2% of hospital stays lasted more than 21 days. Moreover, various initiatives are taken by government and non-government organization to bolster the growth of the market. In 2021, VS Health and the Cancer Treatments Centers of America (CTCA) collaborated to augment the access to chemotherapy at home for qualified patients.

Market Segmentation

The global chemotherapy at home services market is segmented into product, route of administration, cancer type, and company. Based on product, the market is divided into chemotherapy drugs and chemotherapy infusion pumps. Based on route of administration, the market is segmented into oral and intravenous. Based on cancer type, the market is segmented into breast cancer, blood cancer, ovarian cancer, colorectal cancer, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising prevalence of different type of cancer and rising geriatric population base in the country.

Market Players

Portea Medical Pvt. Ltd., HealthCare atHOME, Ubiqare Health Pvt. Ltd., Vitalis Health and Home Care Pty Ltd, Medibank Private Limited, Advocate Medical Group, View Health Pty Ltd, and CVS Health Corporation are some of the leading companies operating in the market.

Report Scope:

In this report, global chemotherapy at home services market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Chemotherapy At Home Services Market, By Product:

Chemotherapy Drugs

Chemotherapy Infusion Pumps

  • Chemotherapy At Home Services Market, By Route of Administration:

Oral

Intravenous

  • Chemotherapy At Home Services Market, By Cancer Type:

Breast Cancer

Blood Cancer

Ovarian Cancer

Colorectal Cancer

Others

  • Chemotherapy At Home Services Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Asia-Pacific

  • China
  • India
  • Japan
  • Australia
  • South Korea

Europe & CIS

  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Chemotherapy At Home Services Market

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Service Overview

2. Research Methodology

3. Impact of COVID-19 on Global Chemotherapy At Home Services Market

4. Executive Summary

5. Voice of Customer

  • 5.1. Cancer Prevalence, By Gender
  • 5.2. Cancer Prevalence, By Age Group
  • 5.3. Cancer Prevalence, By Region
  • 5.4. Factors Contributing Switch To Chemotherapy At Home
  • 5.5. Barriers To Adoption of Chemotherapy At Home Services

6. Global Chemotherapy At Home Services Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Chemotherapy Drugs v/s Chemotherapy Infusion Pumps)
    • 6.2.2. By Route of Administration (Oral v/s Intravenous)
    • 6.2.3. By Cancer Type (Breast Cancer, Blood Cancer, Ovarian Cancer, Colorectal Cancer, Others)
    • 6.2.4. By Company (2021)
    • 6.2.5. By Region
  • 6.3. Market Map

7. North America Chemotherapy At Home Services Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Route of Administration
    • 7.2.3. By Cancer Type
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Chemotherapy At Home Services Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Route of Administration
        • 7.3.1.2.3. By Cancer Type
    • 7.3.2. Mexico Chemotherapy At Home Services Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Route of Administration
        • 7.3.2.2.3. By Cancer Type
    • 7.3.3. Canada Chemotherapy At Home Services Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Route of Administration
        • 7.3.3.2.3. By Cancer Type

8. Europe Chemotherapy At Home Services Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Route of Administration
    • 8.2.3. By Cancer Type
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Chemotherapy At Home Services Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Route of Administration
        • 8.3.1.2.3. By Cancer Type
    • 8.3.2. Germany Chemotherapy At Home Services Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Route of Administration
        • 8.3.2.2.3. By Cancer Type
    • 8.3.3. United Kingdom Chemotherapy At Home Services Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Route of Administration
        • 8.3.3.2.3. By Cancer Type
    • 8.3.4. Italy Chemotherapy At Home Services Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Route of Administration
        • 8.3.4.2.3. By Cancer Type
    • 8.3.5. Spain Chemotherapy At Home Services Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Route of Administration
        • 8.3.5.2.3. By Cancer Type

9. Asia-Pacific Chemotherapy At Home Services Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Route of Administration
    • 9.2.3. By Cancer Type
    • 9.2.4. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Chemotherapy At Home Services Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Route of Administration
        • 9.3.1.2.3. By Cancer Type
    • 9.3.2. India Chemotherapy At Home Services Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Route of Administration
        • 9.3.2.2.3. By Cancer Type
    • 9.3.3. Japan Chemotherapy At Home Services Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Route of Administration
        • 9.3.3.2.3. By Cancer Type
    • 9.3.4. South Korea Chemotherapy At Home Services Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Product
        • 9.3.4.2.2. By Route of Administration
        • 9.3.4.2.3. By Cancer Type
    • 9.3.5. Australia Chemotherapy At Home Services Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Product
        • 9.3.5.2.2. By Route of Administration
        • 9.3.5.2.3. By Cancer Type

10. South America Chemotherapy At Home Services Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Route of Administration
    • 10.2.3. By Cancer Type
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Chemotherapy At Home Services Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Route of Administration
        • 10.3.1.2.3. By Cancer Type
    • 10.3.2. Argentina Chemotherapy At Home Services Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Route of Administration
        • 10.3.2.2.3. By Cancer Type
    • 10.3.3. Colombia Chemotherapy At Home Services Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Route of Administration
        • 10.3.3.2.3. By Cancer Type

11. Middle East and Africa Chemotherapy At Home Services Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product
    • 11.2.2. By Route of Administration
    • 11.2.3. By Cancer Type
    • 11.2.4. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Chemotherapy At Home Services Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product
        • 11.3.1.2.2. By Route of Administration
        • 11.3.1.2.3. By Cancer Type
    • 11.3.2. Saudi Arabia Chemotherapy At Home Services Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product
        • 11.3.2.2.2. By Route of Administration
        • 11.3.2.2.3. By Cancer Type
    • 11.3.3. UAE Chemotherapy At Home Services Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product
        • 11.3.3.2.2. By Route of Administration
        • 11.3.3.2.3. By Cancer Type

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Portea Medical Pvt. Ltd.
  • 14.2. HealthCare atHOME
  • 14.3. Ubiqare Health Pvt. Ltd.
  • 14.4. Vitalis Health and Home Care Pty Ltd
  • 14.5. Medibank Private Limited.
  • 14.6. Advocate Medical Group
  • 14.7. View Health Pty Ltd
  • 14.8. CVS Health Corporation

15. Strategic Recommendations